MARLBOROUGH, Mass.--(BUSINESS WIRE)--Cytyc Corporation (NASDAQ: CYTC) announced today that its stockholders have approved the merger with Hologic, Inc. In excess of 76 percent of the outstanding shares of Cytyc were voted in favor of the transaction at the special meeting. As previously announced on May 20, 2007, Hologic and Cytyc entered into a definitive agreement to combine the two companies in a cash and stock transaction under which Cytyc stockholders would receive 0.52 of a share of Hologic common stock and $16.50 in cash for each share of Cytyc common stock they own for a total consideration of approximately $6.2 billion. The transaction is expected to close early next week, subject to the satisfaction of other previously disclosed closing conditions.
